Heartland BancCorp Earnings Grow 14.7% to $1.8 Million in

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Heartland BancCorp Earnings Grow 14.7% to $1.8 Million in 1Q16 from 1Q15; Increases Quarterly Cash Dividend by 5% to $0.3910 per Share

GAHANNA, Ohio, April 20, 2016 (GLOBE NEWSWIRE) -- Heartland BancCorp (“the company,” and “the bank”) (OTCQB:HLAN), today reported that first quarter net income increased 14.7% to $1.8 million, or $1.12 per diluted share, compared to $1.6 million, or $0.98 per diluted share, in the first quarter of 2015.  Following a $879,000 life insurance benefit, earnings were $2.8 million, or $1.77 per diluted share, in the preceding quarter.

The company also announced its board of directors increased its regular quarterly cash dividend by 5% to $0.3910 per share.  The dividend will be payable July 10, 2016, to shareholders of record as of June 25, 2016, providing a 3.34% current yield at recent market prices. 

“Our first quarter results were a continuation of the momentum that we built in 2015.  Earnings increased 15% for the quarter compared to the first quarter a year ago, propelled by solid loan and deposit growth,” said G. Scott McComb, Chairman, President and CEO.  “While we had a slight uptick in nonperforming loans during the quarter, we believe these to be isolated events and are keeping a careful eye on credit quality.  The greater Columbus market continues to be one of the healthiest economies, not only in the region, but in the country.  We remain well positioned to take advantage of opportunities in our marketplace, as we continue to grow in 2016.”

First Quarter Financial Highlights (at or for the period ended March 31, 2016)

  • Net income was $1.8 million, up from $1.6 million in the first quarter a year ago.
  • Net interest margin remained strong at 3.98% compared to 3.99% in the preceding quarter and 4.05% in the first quarter a year ago.
  • Annualized return on average assets was 0.97%.
  • Annualized return on average equity was 10.76%.
  • Total deposits increased 10.2% to $645.6 million from a year ago.
  • Net loans increased 8.0% to $557.0 million from a year ago.
  • Non-performing assets were $6.1 million, or 0.81% of total assets, at March 31, 2016, compared to $5.2 million, or 0.72%, three months earlier and $3.0 million, or 0.44%, one year earlier.
  • Tangible book value per share increased 9.5% to $43.30 per share compared to $39.53 per share one year earlier.
  • Increased its quarterly cash dividend by 5% to $0.3910 per share, which represents a 3.34% yield based on the March 31, 2016 stock price ($46.77).

In November 2015, Heartland completed a $5.4 million private placement of subordinated notes to accredited investors with fixed and variable rates producing a weighted interest rate of 4.986%.  The proceeds give Heartland the opportunity to build out its business plan and meet the growing demand from clients and the marketplace. 

Balance Sheet Review

“Our loan pipeline remains strong, and as a result, net loans were up $16.0 million, or 3.0% during the quarter.  The agricultural and commercial and industrial (C&I) portfolios continue to show the most growth, increasing 38% and 11%, respectively compared to a year ago,” said McComb.  Net loans increased 3.0% to $557.0 million at March 31, 2016, compared to $541.0 million at December 31, 2015 and increased 8.0% compared to $515.6 million at March 31, 2015. 

Total deposits increased 3.6% to $645.6 million at quarter end, compared to $623.0 million three months earlier and increased 10.2% compared to $586.1 million a year ago.  Demand deposit accounts represented 19.8%, savings, NOW and money market accounts represented 37.2%, and CDs comprised 43.0% of the total deposit portfolio, at March 31, 2016. 

Heartland’s total assets increased 4.3% to $760.8 million at March 31, 2016, compared to $729.6 million three months earlier and increased 12.6% compared to $675.6 million a year earlier.  Shareholders’ equity increased 2.1% to $68.2 million at March 31, 2016, compared to $66.8 million at December 31, 2015 and increased 10.1% compared to $61.9 million one year ago.  At quarter end, Heartland’s tangible book value increased 2.1% to $43.30 per share compared to $42.4 per share three months earlier and increased 9.5% from $39.53 per share one year earlier.

Operating Results

Total revenues (net interest income before the provision for loan losses, plus non-interest income) increased 11.7% to $7.5 million in the first quarter, compared to $6.8 million in the first quarter a year ago, and were down compared to $8.3 million in the preceding quarter.  Excluding the fourth quarter $879,000 benefit in excess of life insurance value, total revenues were $7.4 million in the preceding quarter.  Net interest income before the provision for loan loss increased 10.5% to $6.7 million in the first quarter of 2016, compared to $6.1 million in the first quarter a year ago, and increased 1.9% compared to $6.6 million in the preceding quarter.  

“We maintained a solid net interest margin during the quarter with only one basis point of contraction, due to continued loan and deposit pricing discipline,” said McComb.  Heartland’s net interest margin was 3.98% in the first quarter of 2016, compared to 3.99% in the preceding quarter and 4.05% in the first quarter a year ago. 

Heartland’s noninterest income increased 22.3% to $830,000 in the first quarter, compared to $679,000 in the first quarter a year ago, largely as a result of the net gains and commissions on loan sales.  In the preceding quarter total noninterest income was $1.7 million, following a $879,000 benefit in excess of life insurance cash value from a policy payout. 

First quarter noninterest expenses were $4.8 million, compared to $4.5 million in the preceding quarter and $4.3 million in the first quarter a year ago.  The year-over-year increase is primarily attributable to an increase in loan production, along with a management realignment to poise the company for continued growth, which led to overall higher employee and incentive costs.

Credit Quality

"Nonaccrual loans and past due loans still accruing increased again during the quarter, primarily due to a few individuals that were slow in making payments," said McComb.  “However, we continued to have no foreclosed assets on the books at quarter end.  We believe these few problematic loans are isolated and not indicative of the overall quality of the loan portfolio.”

Nonaccrual loans were $3.6 million at March 31, 2016, compared to $3.3 million three months earlier, and $2.4 million a year earlier.  Loans past due 90 days and still accruing also increased to $2.6 million from $1.9 million at the end of the fourth quarter and $454,000 a year ago.  There were $700,000 in restructured loans included in nonaccrual loans at the end of the first quarter of 2016, as compared to $600,000 at March 31, 2015.

Performing restructured loans that were not included in nonaccrual loans at the end of the first quarter of 2016 remained at $4.3 million, the same as in the preceding quarter and a decrease compared to $4.5 million a year ago.  Borrowers who are in financial difficulty and who have been granted concessions that may include interest rate reductions, term extensions, or payment alterations are categorized as restructured loans.  “We present restructured loans that are performing separately from those that are classified as nonaccrual to provide more information on this category of loans and to differentiate between accruing performing and nonperforming restructured loans,” added McComb.

There was no other real estate owned (OREO) and other non-performing assets on the books at March 31, 2016, the same as at the preceding quarter end.  OREO was $117,000 at March 31, 2015.

Heartland’s nonperforming assets (NPAs), consisting of nonperforming loans, OREO, and loans delinquent 90 days or more, were $6.1 million, or 0.81% of assets, at March 31, 2016, compared to $5.2 million, or 0.72% of assets, three months earlier, and $3.0 million, or 0.44% of assets a year ago. 

The first quarter provision for loan losses was $240,000, compared to $120,000 in the preceding quarter and $240,000 in the first quarter a year ago.  As of March 31, 2016, the allowance for loan losses represented 165.7% of nonaccrual loans compared to 172.1% three months earlier, and 221.2% one year earlier.

Heartland’s net charge-offs were $51,000 in the first quarter compared to $54,000 in the preceding quarter, and $319,000 in the first quarter a year ago.  The allowance for loan losses was $5.9 million, or 1.05% of total loans at March 31, 2016, compared to $5.7 million, or 1.04% of total loans at December 31, 2015, and $5.3 million, or 1.01% of total loans a year ago.

About Heartland BancCorp

Heartland BancCorp is a registered Ohio bank holding company and the parent of Heartland Bank, which operates twelve full-service banking offices. Heartland Bank, founded in 1911, provides full service commercial, small business, and consumer banking services; alternative investment services; insurance services; and other financial products and services.  Heartland Bank is a member of the Federal Reserve, a member of the FDIC and an Equal Housing Lender. Heartland BancCorp is currently quoted on the OTC Markets (OTCQB) under the symbol HLAN. Learn more about Heartland Bank at HeartlandBank.com .  

In May 2015, Heartland was ranked #77 on the American Banker magazine’s list of Top 200 Publicly Traded Community Banks and Thrifts based on three-year average return on equity (“ROE”) as of 12/31/14.

Safe Harbor Statement

This release contains forward-looking statements that reflect management's current views of future events and operations. These forward-looking statements are based on information currently available to the Company as of the date of this release.  It is important to note that these forward-looking statements are not guarantees of future performance and involve risks and uncertainties, including, but not limited to, the ability of the Company to implement its strategy and expand its lending operations.

 

Heartland BancCorp
Consolidated Balance Sheets
 
Assets     March 31, 2016   Dec. 31, 2015   March 31, 2015
  Cash and cash equivalents $ 50,409,176 $ 36,994,171 $ 31,078,674
  Available-for-sale securities   116,371,892   114,638,733   100,811,843
               
  Held-to-maturity securities, fair value $6,368,233 and $6,922,387 at March 31, 2016 and 2015, respectively and $6,409,962 at December 31, 2015   5,988,749   6,044,094   6,453,351
               
  Loans, net of allowance for loan losses of $5,904,718 and $5,271,174 at March 31, 2016 and 2015, respectively and $5,715,827 at December 31, 2015   556,966,762   540,958,372   515,645,398
  Premises and equipment   13,614,047   13,506,350   12,880,648
  Nonmarketable equity securities   2,658,239   2,658,239   2,655,439
  Foreclosed assets held for sale   -   -   117,457
  Interest receivable   2,537,113   1,958,082   2,359,955
  Receivables due from loan sales            
  Goodwill   417,353   417,353   417,353
  Deferred income taxes   1,765,794   1,574,075   1,881,258
  Life insurance assets   9,392,956   9,327,518    
  Other   647,980   1,516,000   1,308,202
  Total assets $ 760,770,061 $ 729,592,987 $ 675,609,578
               
Liabilities and Shareholders' Equity            
Liabilities            
  Deposits            
  Demand $ 127,783,871 $ 139,226,242 $ 109,641,986
  Saving, NOW and money market   240,534,031   219,076,813   220,201,722
  Time   277,293,146   264,651,203   256,227,173
  Total deposits   645,611,048   622,954,258   586,070,881
  Short-term borrowings   30,657,576   29,150,118   22,882,863
  Long-term debt   5,460,000   5,460,000   -
  Interest payable and other liabilities   10,883,276   5,270,849   4,769,023
  Total liabilities   692,611,900   662,835,225   613,722,767
               
  Shareholders' Equity            
  Common stock, without par value; authorized 5,000,000 shares;  issued 2016 -  1,564,581 shares 2015 -  1,554,921 shares and December 2015 - 1,564,581 shares   23,913,514   23,872,599   23,577,337
  Retained earnings   43,187,045   41,991,488   37,159,060
  Accumulated other comprehensive income (expense)   1,057,602   893,675   1,150,414
  Total shareholders' equity   68,158,161   66,757,762   61,886,811
  Total liabilities and shareholders' equity $ 760,770,061 $ 729,592,987 $ 675,609,578
  Book value per share $ 43.56 $ 42.67 $ 39.80
 
Heartland BancCorp
Consolidated Statements of Income
 
      Three Months Ended 
Interest Income     March 31, 2016   Dec. 31, 2015     March 31, 2015
Loans $ 6,801,720 $ 6,645,404   $ 6,140,166
Securities              
Taxable   435,385   424,204     303,519
Tax-exempt   410,970   395,358     385,458
Other   36,211   15,888     8,293
Total interest income   7,684,286   7,480,854     6,837,436
Interest Expense                
Deposits   891,924   851,796     753,517
Borrowings   74,222   39,234     3,677
Total interest expense   966,146   891,030     757,194
Net Interest Income     6,718,140   6,589,824     6,080,242
Provision for Loan Losses     240,000   120,000     240,000
Net Interest Income After Provision for Loan Losses     6,478,140   6,469,824     5,840,242
Noninterest income                
Service charges   454,649   477,606     467,519
Net Gains and commissions on loan sales   122,725   34,621     39,526
Net realized gains on available-for-sale securities   64,286   1,357     8,434
Net realized gain/(loss) on sales of foreclosed assets   -   -     58
(Loss) gain on sale of premises and equipment   -   -     -
Benefit in excess of life insurance cash value   -   879,488     -
Other   188,096   272,255     163,196
Total noninterest income   829,756   1,665,326     678,733
Noninterest Expense                
Salaries and employee benefits   2,934,564   2,800,345     2,487,769
Net occupancy and equipment expense   473,973   456,349     441,724
Data processing fees   265,536   265,293     272,083
Professional fees   112,039   64,706     170,499
Marketing expense   149,349   134,990     141,000
Printing and office supplies   44,197   31,786     49,103
State franchise taxes   139,500   105,981     105,982
FDIC Insurance premiums   98,000   93,000     111,000
Other   608,113   593,635     568,371
Total noninterest expense   4,825,271   4,546,085     4,347,531
Income before Income Tax     2,482,625   3,589,065     2,171,444
Provision for Income Taxes     704,420   780,246     621,419
Net Income   $ 1,778,205 $ 2,808,819   $ 1,550,025
Basic Earnings Per Share   $ 1.14 $ 1.80   $ 1.00
Diluted Earnings Per Share   $ 1.12 $ 1.77   $ 0.98
 

 

                 
ADDITIONAL FINANCIAL INFORMATION                
(Dollars in thousands except per share amounts)(Unaudited)       Three Months Ended
        March 31, 2016   Dec. 31, 2015   March 31, 2015
Performance Ratios:                
Return on average assets         0.97 %     1.59 %     0.95 %
Return on average equity         10.76 %     17.51 %     10.26 %
Net interest margin         3.98 %     3.99 %     4.05 %
Efficiency ratio         64.48 %     55.08 %     64.40 %
                 
Asset Quality Ratios and Data:       As of or for the Three Months Ended
        March 31, 2016   Dec. 31, 2015   March 31, 2015
Non accrual loans       $ 3,563     $ 3,320     $ 2,383  
Loans past due 90 days and still accruing         2,564       1,919       454  
Non-performing investment securities         -       -       -  
OREO and other non-performing assets         -       -       117  
Total non-performing assets       $ 6,127     $ 5,239     $ 2,954  
                 
Non-performing assets to total assets         0.81 %     0.72 %     0.44 %
Net charge-offs quarter ending       $ 51     $ 54     $ 319  
                 
Allowance for loan loss       $ 5,905     $ 5,716     $ 5,271  
Non accrual loans       $ 3,563     $ 3,320     $ 2,383  
Allowance for loan loss to non accrual loans         165.73 %     172.17 %     221.19 %
Allowance for loan losses to loans outstanding         1.05 %     1.04 %     1.01 %
                 
Book Values:                
Total shareholders' equity       $ 68,158     $ 66,758     $ 61,887  
Less, goodwill         417       417       417  
Shareholders' equity less goodwill       $ 67,741     $ 66,341     $ 61,469  
Common shares outstanding         1,564,581       1,564,581       1,554,921  
Book value per common share       $     43.56     $     42.67     $     39.80  
                 
Tangible book value per common share       $     43.30     $     42.40     $     39.53  
                             

Contacts: G. Scott McComb Chairman, President & CEO Heartland BancCorp 614-337-4600

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 286

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 238

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 380

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 305

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 310

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 131

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 161

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
Midea's R290 Tech: Real Green Cooling Revolution?

Updated Category News Views 0

A Fresh Breeze in Sustainable Cooling In the middle of Kigali’s innovation oasis, Midea RAC stood out at MOP38, the 38th Meeting of the Parties to the Montreal Protocol, flexing its sustainable tech muscles. We're talking about their R290 air conditioning technology—a natural refrigerant with zero ozone footprint and a global warming potential of a mere three. This is...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 0

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 277

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting Breakthroughs in Lung Cancer Treatment with Reqorsa

Updated Category News Views 182

Innovative Advances in Lung Cancer Treatment The fight against lung cancer continues to evolve, showcasing promising advancements that bring new hope to patients. Genprex, Inc. is at the forefront of this battle with its revolutionary gene therapy known as Reqorsa. This cutting-edge treatment has been developed specifically to target KRAS mutation in non-small cell lung...

Continue Reading
EfTEN United Property Fund Reports October Earnings and NAV

Updated Category News Views 192

Insights into EfTEN United Property Fund's Recent Performance EfTEN United Property Fund demonstrated a net profit of 110 thousand euros for October, totaling 2.214 million euros for the first ten months of the year, marking a significant improvement from 724 thousand euros during the same period last year. This impressive financial outcome led to a distribution to...

Continue Reading
Cardiff Oncology Reports Encouraging Results in mCRC Trial

Updated Category News Views 236

Cardiff Oncology Reveals Promising Clinical Trial Results Cardiff Oncology, Inc. (Nasdaq: CRDF), a pioneering clinical-stage biotechnology company, has recently announced encouraging results from its ongoing CRDF-004 clinical trial. This randomized Phase 2 trial is investigating the effects of onvansertib in patients suffering from first-line RAS-mutated metastatic...

Continue Reading
Japan's Growing Casting Polyurethane Market and Its Future

Updated Category News Views 127

Japan's Casting Polyurethane Market: A Rising Force The Japan casting polyurethane market is on the verge of significant transformation, anticipated to elevate from a valuation of US$ 134.74 million to a remarkable US$ 248.24 million by 2033. This growth trajectory highlights a compelling compound annual growth rate (CAGR) of 7.08%, revealing the underlying strength...

Continue Reading
Hudson Technologies Faces Challenges Amid Downgrade by B.Riley

Updated Category News Views 353

B.Riley Downgrades Hudson Technologies Stock In a recent market statement, B.Riley has lowered its outlook on Hudson Technologies (NASDAQ: HDSN), shifting the stock rating from Buy to Neutral. This adjustment comes amidst new growth projections adjusted downwards from +16.6% to +8.5%. The modification in expectations has been linked to ongoing pressures on...

Continue Reading